|
2016
|
Invention
|
Process for purification of darbepoetin alfa.
The present invention provides sequential chromato... |
|
2013
|
Invention
|
Process for purification of aprepitant.
The present invention relates to a process for obtaining... |
|
2012
|
Invention
|
Polymorphs of efavirenz. The present invention relates to novel amorphous and crystalline forms o... |
|
2011
|
Invention
|
Polymorphs of esomeprazole salts.
The present invention relates to a high assayed esomeprazole m... |
|
|
Invention
|
Hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride pol... |
|
2010
|
Invention
|
Gemifloxacin process and polymorphs.
The present invention provides a novel process for the prep... |
|
2009
|
Invention
|
Process for the preparation of lercanidipine. The invention provides a novel process for the prep... |
|
|
Invention
|
Novel crystalline forms of lamotrigine.
The present invention relates to novel crystalline forms... |
|
|
Invention
|
Pharmaceutical compositions of valdecoxib.
The present invention relates to novel crystalline fo... |
|
|
Invention
|
Nucleoside derivatives. The present patent application relates to the novel nucleoside derivative... |
|
|
Invention
|
Amorphous esomeprazole hydrate. The present invention relates to a novel amorphous form of esomep... |
|
|
Invention
|
Process of making sertraline form i. The present invention discloses novel and improved processes... |
|
|
Invention
|
Process of making sertraline form ii. The present invention discloses novel and improved processe... |
|
2008
|
Invention
|
Process for preparation of cefprozil intermediate. The present invention relates to a process for... |
|
2007
|
Invention
|
Process for pure irbesartan.
The present invention provides an improved and commercially viable ... |
|
|
Invention
|
Process for pure irbesartan. The present invention provides an improved and commercially viable p... |
|
|
Invention
|
Polymorphs of esomeprazole salts. The present invention relates to a high assayed esomeprazole ma... |
|
|
Invention
|
Process for preparation of enantiomerically pure esomeprazole. The present invention provides an ... |
|
|
Invention
|
A process for preparation of enantiomerically pure esomeprazole. The present invention provides a... |
|
|
Invention
|
Novel hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochlori... |
|
|
Invention
|
A novel hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochlo... |
|
|
Invention
|
Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan. The presen... |
|
|
Invention
|
Process for erlotinib hydrochloride. The present invention provides an improved and commercially ... |
|
|
Invention
|
An improved process for erlotinib hydrochloride. The present invention provides an improved and c... |
|
|
Invention
|
Novel crystalline forms of atovaquone.
The present invention relates to two novel and stable cry... |
|
|
Invention
|
Novel crystalline forms of atovaquone. The present invention relates to two novel and stable crys... |
|
|
Invention
|
Improved process for amorphous rabeprazole sodium. The present invention provides an improved and... |
|
2006
|
Invention
|
Process for eprosartan.
The present invention provides an improved and commercially viable proce... |
|
|
Invention
|
novel crystalline form of lansoprazole.
The present invention relates to a novel and stable cry... |
|
|
Invention
|
Process for preparation of prulifloxacin using novel intermediates.
The present invention provid... |
|
|
Invention
|
Process for rimonabant.
The present invention provides an improved and commercially viable proce... |
|
|
Invention
|
Novel polymorphs of rimonabant.
The present invention discloses novel and stable polymorphs of r... |
|
|
Invention
|
Solid faropenem free acid.
The present invention provides solid form of faropenem free acid, its... |
|
|
Invention
|
Process for isolation of desired isomers of nebivolol intermediates. The present invention relate... |
|
|
Invention
|
Process for obtaining pure oseltamivir. The present invention provides a process for obtaining hi... |
|
2005
|
Invention
|
Process for oseltamivir phosphate. The present invention provides an improved and commercially vi... |
|
|
Invention
|
Process for amorphous esomeprazole.
The present invention relates to a commercially viable proce... |
|
|
Invention
|
Process for acyclic phosphonate nucleotide analogs. 4-Dimethylaminomethyledino-9-(2-phosphono met... |
|
|
Invention
|
Process for the preparation of didanosine using novel intermediates. The present invention relate... |
|
|
Invention
|
Gemifloxacin process and polymorphs. The present invention provides a novel process for the prepa... |
|
|
Invention
|
Cefdinir process.
The present invention provides an improved process for the preparation of high... |
|
|
Invention
|
Novel crystalline form of rupatadine free base.
The present invention relates to a novel crystal... |
|
|
Invention
|
Process for ziprasidone using novel intermediates.
The present invention relates to a novel proc... |
